Peptide-based mostly vectors have obtained notice for their specificity in binding to receptors overexpressed in breast cancer cells, probably overcoming challenges relevant to minimal internalization. Co-formulation with other permeation enhancers, enzyme inhibitors, and hydrogels have also been used to allow the oral administration of other pe